Pharmacologic therapy for acute MI in the elderly

Robert Forman, W. Aronow

Research output: Contribution to journalArticle

Abstract

Mortality and morbidity from acute myocardial infarction (MI) are much higher in the elderly than in younger patients, creating a greater potential for improving the outcome with aggressive medical therapy. Elderly patients can benefit significantly from early thrombolysis with relatively few complications; aspirin and heparin-particularly in conjunction with thrombolytic agents-are highly effective. Long-term β-blockade can improve survival markedly, and the use of intravenous angiotensin-converting enzyme inhibitors before discharge decreases both mortality and the risk of heart failure. Early results for magnesium sulfate are promising as well.

Original languageEnglish (US)
Pages (from-to)29-36
Number of pages8
JournalDrug Therapy
Volume23
Issue number8
StatePublished - 1993

Fingerprint

Myocardial Infarction
Magnesium Sulfate
Fibrinolytic Agents
Mortality
Angiotensin-Converting Enzyme Inhibitors
Aspirin
Heparin
Heart Failure
Morbidity
Survival
Therapeutics

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Pharmacologic therapy for acute MI in the elderly. / Forman, Robert; Aronow, W.

In: Drug Therapy, Vol. 23, No. 8, 1993, p. 29-36.

Research output: Contribution to journalArticle

Forman, R & Aronow, W 1993, 'Pharmacologic therapy for acute MI in the elderly', Drug Therapy, vol. 23, no. 8, pp. 29-36.
Forman, Robert ; Aronow, W. / Pharmacologic therapy for acute MI in the elderly. In: Drug Therapy. 1993 ; Vol. 23, No. 8. pp. 29-36.
@article{9dd87d6eb6fc4ab78f5201d0fe0d4509,
title = "Pharmacologic therapy for acute MI in the elderly",
abstract = "Mortality and morbidity from acute myocardial infarction (MI) are much higher in the elderly than in younger patients, creating a greater potential for improving the outcome with aggressive medical therapy. Elderly patients can benefit significantly from early thrombolysis with relatively few complications; aspirin and heparin-particularly in conjunction with thrombolytic agents-are highly effective. Long-term β-blockade can improve survival markedly, and the use of intravenous angiotensin-converting enzyme inhibitors before discharge decreases both mortality and the risk of heart failure. Early results for magnesium sulfate are promising as well.",
author = "Robert Forman and W. Aronow",
year = "1993",
language = "English (US)",
volume = "23",
pages = "29--36",
journal = "Drug Therapy",
issn = "0001-7094",
number = "8",

}

TY - JOUR

T1 - Pharmacologic therapy for acute MI in the elderly

AU - Forman, Robert

AU - Aronow, W.

PY - 1993

Y1 - 1993

N2 - Mortality and morbidity from acute myocardial infarction (MI) are much higher in the elderly than in younger patients, creating a greater potential for improving the outcome with aggressive medical therapy. Elderly patients can benefit significantly from early thrombolysis with relatively few complications; aspirin and heparin-particularly in conjunction with thrombolytic agents-are highly effective. Long-term β-blockade can improve survival markedly, and the use of intravenous angiotensin-converting enzyme inhibitors before discharge decreases both mortality and the risk of heart failure. Early results for magnesium sulfate are promising as well.

AB - Mortality and morbidity from acute myocardial infarction (MI) are much higher in the elderly than in younger patients, creating a greater potential for improving the outcome with aggressive medical therapy. Elderly patients can benefit significantly from early thrombolysis with relatively few complications; aspirin and heparin-particularly in conjunction with thrombolytic agents-are highly effective. Long-term β-blockade can improve survival markedly, and the use of intravenous angiotensin-converting enzyme inhibitors before discharge decreases both mortality and the risk of heart failure. Early results for magnesium sulfate are promising as well.

UR - http://www.scopus.com/inward/record.url?scp=0027291130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027291130&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 29

EP - 36

JO - Drug Therapy

JF - Drug Therapy

SN - 0001-7094

IS - 8

ER -